Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen Brinker

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of the American Academy of Dermatology|April 26, 2011
Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patientsNamita Kothary, Ida-Lina Diak, Allen Brinker, et al.
Journal of Neurology|April 18, 2026
Corneal edema: an underrecognized safety risk of amantadineDavid Croteau, Anne Tobenkin, Vicky Chan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2020
Expanding spectrum of opportunistic infections associated with dimethyl fumarateTiffany Kim, David Croteau, Allen Brinker, et al.
Drug Safety|September 27, 2005
Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitorsLois La Grenade, Lauren Lee, Joyce Weaver, et al.
Annals of Internal Medicine|April 25, 2017
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting SystemSusan J Bersoff-Matcha, Kelly Cao, Mihaela Jason, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2025
Anaphylaxis and glatiramer acetateTiffany B Kim, Jenni Yoon Lee, Allen Brinker, et al.
Multiple Sclerosis and Related Disorders|November 14, 2024
Progressive multifocal leukoencephalopathy associated with sphingosine-1-phosphate receptor modulators: A large case seriesDavid Croteau, Tiffany Kim, Vicky Chan, et al.
Headache|April 2, 2026
Arterial hypertension: A safety risk of calcitonin gene-related peptide ligand and receptor blocker classDavid Croteau, Anne Tobenkin, Suprat Saely, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2023
Immune-mediated colitis associated with ocrelizumab: A new safety riskTiffany Kim, Allen Brinker, David Croteau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 11, 2025
Severe gastrointestinal adverse reactions including perforation, ulceration, hemorrhage, and obstruction: A fumaric acid ester class new safety riskTiffany Kim, Allen Brinker, David Croteau, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of the American Academy of Dermatology|April 26, 2011
Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patientsNamita Kothary, Ida-Lina Diak, Allen Brinker, et al.
Journal of Neurology|April 18, 2026
Corneal edema: an underrecognized safety risk of amantadineDavid Croteau, Anne Tobenkin, Vicky Chan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2020
Expanding spectrum of opportunistic infections associated with dimethyl fumarateTiffany Kim, David Croteau, Allen Brinker, et al.
Drug Safety|September 27, 2005
Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitorsLois La Grenade, Lauren Lee, Joyce Weaver, et al.
Annals of Internal Medicine|April 25, 2017
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting SystemSusan J Bersoff-Matcha, Kelly Cao, Mihaela Jason, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2025
Anaphylaxis and glatiramer acetateTiffany B Kim, Jenni Yoon Lee, Allen Brinker, et al.
Multiple Sclerosis and Related Disorders|November 14, 2024
Progressive multifocal leukoencephalopathy associated with sphingosine-1-phosphate receptor modulators: A large case seriesDavid Croteau, Tiffany Kim, Vicky Chan, et al.
Headache|April 2, 2026
Arterial hypertension: A safety risk of calcitonin gene-related peptide ligand and receptor blocker classDavid Croteau, Anne Tobenkin, Suprat Saely, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2023
Immune-mediated colitis associated with ocrelizumab: A new safety riskTiffany Kim, Allen Brinker, David Croteau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 11, 2025
Severe gastrointestinal adverse reactions including perforation, ulceration, hemorrhage, and obstruction: A fumaric acid ester class new safety riskTiffany Kim, Allen Brinker, David Croteau, et al.
Pageof 3